Skip to main content
OpenTrials

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,921 public trials 503 recruiting studies
Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Completed

A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXA

NCT00693186

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • Unità Operativa Semplice di Epidemiologia (UOSE) Quarto, Napoli, Italy
  • Azienda per i Servizi Sanitari n. 5 "Bassa Friulana" Latisana, Udine, Italy
  • Ospedale Maggiore di Modica - Via Resistenza Partigiana (c/o Ospedale Maggiore) Modica, Italy
  • AUSL n. 7 di Ragusa Servizio di Epidemiologia Via G. Di Vittorio 59/c Ragusa, Italy
View Trial Details
Completed

Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA

NCT02012998

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • Sanofi Pasteur MSD Investigational Site 004 Bologna, Italy
  • Sanofi Pasteur MSD Investigational Site 009 Cagliari, Italy
  • Sanofi Pasteur MSD Investigational Site 005 Capannori, Italy
  • Sanofi Pasteur MSD Investigational Site 003 Chiavari, Italy
View Trial Details
Completed

A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children

NCT00297206

Conditions
DNA Virus Infections, Herpes Simplex, Herpesviridae Infections, +6 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site Jacksonville, Florida, United States
View all 13 locations
View Trial Details
Completed

An Observational Study in Participants With Chronic Hepatitis B (CHB) Receiving Therapy With Peginterferon Alfa-2a 40 Kilodaltons (kD) (PEGASYS) - The PRO B Study

NCT02201407

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Clinic for Gastroenterology and Hepatology Belgrade, Serbia
  • Clinical Center of Serbia; Institute For Infectious Diseases Belgrade, Serbia
  • Clinical Center Zemun Belgrade, Serbia
  • Clinic for Infectious Diseases CC Kragujevac Kragujevac, Serbia
View Trial Details

Related conditions